STRATEGIC INNOVATIVE SOLUTION (SIS)

The contract, identified as RMS #862 and associated with Line Item 14034 and PR #000HCJDC-2024-84891, involves the Centers for Disease Control and Prevention (CDC) and pertains to a Strategic Innovative Solution (SIS). The contract's total value amounts to $4,326,169.77, divided across a base period valued at $1,219,114.88 and three option periods: Option I at $1,271,282.98, Option II at $896,810.90, and Option III at $938,961.01. This arrangement suggests a multi-year engagement with funding allocated to support ongoing work across multiple phases. Personnel involved in this contract include several individuals, each associated with designated funding amounts around $195,000, such as Micro II-TBD, Vice-Heather Colley, Brandi Turner Smith, Anna Rose Hutcheson, Marcos De Almeida, and Dexter Thompson, with Silvia Dimitrova assigned slightly less at $155,000. The contract details are relatively high-level with no specific location or agency type set aside indicated. The point of contact for program inquiries is Cho Yau Ling, while the contracting officer remains to be determined. Overall, this contract represents a significant investment by the CDC in strategic innovation efforts, supporting a skilled team over a planned multi-year period.